tradingkey.logo

Nuwellis Inc

NUWE

6.910USD

-2.190-24.07%
Horário de mercado ETCotações atrasadas em 15 min
30.22MValor de mercado
PerdaP/L TTM

Nuwellis Inc

6.910

-2.190-24.07%
Mais detalhes de Nuwellis Inc Empresa
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Informações da empresa
Código da empresaNUWE
Nome da EmpresaNuwellis Inc
Data de listagemFeb 16, 2012
CEOErb (John L)
Número de funcionários38
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 16
Endereço12988 Valley View Rd
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55344
Telefone19523454200
Sitehttps://www.nuwellis.com/
Código da empresaNUWE
Data de listagemFeb 16, 2012
CEOErb (John L)
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Erb (John L)
Erb (John L)
Chairman of the Board, Interim President and Interim Chief Executive Officer
Chairman of the Board, Interim President and Interim Chief Executive Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Robert B. (Rob) Scott
Mr. Robert B. (Rob) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Erb (John L)
Erb (John L)
Chairman of the Board, Interim President and Interim Chief Executive Officer
Chairman of the Board, Interim President and Interim Chief Executive Officer
803.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
3.00
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
3.00
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Mr. Robert B. (Rob) Scott
Mr. Robert B. (Rob) Scott
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 16 de jul
Atualizado em: qua, 16 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Bigger Capital Funds, LP
1.08%
XTX Markets LLC
0.08%
HRT Financial LP
0.05%
Geode Capital Management, L.L.C.
0.02%
Erb (John L)
0.02%
Other
98.76%
Investidores
Investidores
Proporção
Bigger Capital Funds, LP
1.08%
XTX Markets LLC
0.08%
HRT Financial LP
0.05%
Geode Capital Management, L.L.C.
0.02%
Erb (John L)
0.02%
Other
98.76%
Tipos de investidores
Investidores
Proporção
Hedge Fund
1.10%
Venture Capital
0.08%
Investment Advisor
0.05%
Investment Advisor/Hedge Fund
0.03%
Individual Investor
0.02%
Research Firm
0.02%
Other
98.70%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
27
9.84K
1.30%
+7.06K
2025Q1
26
140.31K
3.15%
+23.64K
2024Q4
25
113.78K
2.60%
+73.44K
2024Q3
29
65.32K
2.68%
+45.76K
2024Q2
28
42.02K
3.15%
+30.15K
2024Q1
26
9.25K
4.91%
+1.97K
2023Q4
26
6.22K
6.75%
+3.61K
2023Q3
35
1.28K
4.82%
-1.76K
2023Q2
36
1.31K
5.00%
-797.00
2023Q1
36
712.00
4.39%
-1.50K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Bigger Capital Funds, LP
5.69K
1.08%
+5.69K
--
Jun 09, 2025
XTX Markets LLC
422.00
0.08%
+422.00
--
Mar 31, 2025
HRT Financial LP
251.00
0.05%
+251.00
--
Mar 31, 2025
Geode Capital Management, L.L.C.
816.00
0.02%
+83.00
+11.32%
Mar 31, 2025
Erb (John L)
52.38K
1.1%
+52.38K
--
Jun 10, 2025
Virtu Americas LLC
645.00
0.01%
+645.00
--
Mar 31, 2025
Citadel Advisors LLC
465.00
0.01%
+185.00
+66.07%
Mar 31, 2025
Two Sigma Investments, LP
438.00
0.01%
+169.00
+62.83%
Mar 31, 2025
The Vanguard Group, Inc.
46.00
0%
--
--
May 31, 2025
Tower Research Capital LLC
146.00
0%
+32.00
+28.07%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Dec 09, 2022
Merger
100<1
Dec 09, 2022
Merger
100<1
Data
Tipo
Proporção
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Jun 26, 2024
Merger
35<1
Dec 09, 2022
Merger
100<1
Dec 09, 2022
Merger
100<1
Dec 09, 2022
Merger
100<1
Dec 09, 2022
Merger
100<1
Oct 17, 2020
Merger
30<1
Oct 17, 2020
Merger
30<1
Ver Mais
KeyAI